Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer

V. C. Dieras, H. S. Han, B. Kaufman, H. Wildiers, M. Friedlander, J-P. Ayoub, S. L. Puhalla, I. Bondarenko, M. Campone, E. H. Jakobsen, M. Jalving, C. Oprean, M. Palacova, Y. H. Park, Y. Shparyk, E. Yanez, M. Dudley, C. K. Ratajczak, D. Maag, B. K. Arun

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberLBA9
JournalAnnals of Oncology
Volume30
Issue numberSuppl. 5
Pages (from-to)857-858
ISSN0923-7534
DOIs
Publication statusPublished - Oct 2019
Event44th Congress of the European Society for Medical Oncology - Barcelona, Spain
Duration: 27. Sep 20191. Oct 2019

Conference

Conference44th Congress of the European Society for Medical Oncology
CountrySpain
CityBarcelona
Period27/09/201901/10/2019

Cite this

Dieras, V. C., Han, H. S., Kaufman, B., Wildiers, H., Friedlander, M., Ayoub, J-P., Puhalla, S. L., Bondarenko, I., Campone, M., Jakobsen, E. H., Jalving, M., Oprean, C., Palacova, M., Park, Y. H., Shparyk, Y., Yanez, E., Dudley, M., Ratajczak, C. K., Maag, D., & Arun, B. K. (2019). Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer. Annals of Oncology, 30(Suppl. 5), 857-858. [LBA9]. https://doi.org/10.1093/annonc/mdz394.008